Y. H. Bae and K. Park, Targeted drug delivery to tumors: myths, reality and possibility, J Control Release, vol.153, pp.198-205, 2011.

S. Yao, Y. Zhu, and L. Chen, Advances in targeting cell surface signalling molecules for immune modulation, Nat Rev Drug Discov, vol.12, pp.130-146, 2013.

H. Nasiri, Z. Valedkarimi, . Aghebati-maleki-l, and J. Majidi, Antibody-drug conjugates: promising and efficient tools for targeted cancer therapy, J Cell Physiol, vol.233, pp.6441-6457, 2018.

S. Garcia-alonso, O. A. Pandiella, and A. , Resistance to antibody-drug conjugates, Cancer Res, vol.78, pp.2159-2166, 2018.

K. Sandvig, M. L. Torgersen, N. Engedal, T. Skotland, and T. Iversen, Protein toxins from plants and bacteria: probes for intracellular transport and tools in medicine, FEBS Lett, vol.584, pp.2626-2634, 2010.

U. Distler, J. Souady, . H?, and I. Drmi-c-hofman, Shiga toxin receptor Gb3Cer/CD77: Tumorassociation and promising therapeutic target in pancreas and colon cancer, PLoS ONE, vol.4, issue.8, 2009.

E. B. Watkins, J. Majewski, E. Y. Chi, H. Gao, J. Florent et al., Shiga toxin induces lipid compression: a mechanism for generating membrane curvature, Nano Lett, vol.19, pp.7365-7369, 2019.

J. E. Mckenzie, B. Raisley, X. Zhou, N. Naslavsky, T. Taguchi et al., Retromer guides STxB and CD8-M6PR from early to recycling endosomes, EHD1 guides STxB from recycling endosome to Golgi, Traffic, vol.13, pp.1140-1159, 2012.

J. E. Mckenzie, The Recycling Endosome is Required for Transport of Retrograde Toxins, 2009.

H. Renard, M. D. Garcia-castillo, V. Chambon, C. Lamaze, and L. Johannes, Shiga toxin stimulates clathrinindependent endocytosis of the VAMP2, VAMP3 and VAMP8 SNARE proteins, J Cell Sci, vol.128, pp.2891-2902, 2015.

C. Batisse, E. Dransart, L. Brulle, S. Bai, S. Godefroy et al., A new delivery system for auristatin in STxB-drug conjugate therapy, Eur J Med Chem, vol.95, pp.483-491, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02137225

P. Barta, . Bj?, and K. Andersson, Circumventing the requirement of binding saturation for receptor quantification using interaction kinetic extrapolation, Nucl Med Biol, vol.32, pp.3-7, 2011.

P. E. Geyer, M. Maak, U. Nitsche, M. Perl, A. Novotny et al., Gastric adenocarcinomas express the glycosphingolipid Gb3/CD77: targeting of gastric cancer cells with Shiga toxin B-subunit, Mol Cancer Ther, vol.15, pp.1008-1017, 2016.

V. Kostova, E. Dransart, M. Azoulay, L. Brulle, S. Bai et al., Targeted Shiga toxin-drug conjugates prepared via Cufree click chemistry, Bioorg Med Chem, vol.23, pp.7150-7157, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01298164

K. M. Gallegos, D. G. Conrady, S. S. Karve, T. S. Gunasekera, A. B. Herr et al., Shiga toxin binding to glycolipids and glycans, PLoS One, vol.7, p.30368, 2012.

H. Nakajima, N. Kiyokawa, Y. U. Katagiri, T. Taguchi, T. Suzuki et al., Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance, J Biol Chem, vol.276, pp.42915-42922, 2001.

O. M. Sch?-utte, D. B. Werz, L. J. Patalag, L. Weber, A. Ries et al., ) 2-Hydroxy fatty acid enantiomers of Gb3 impact Shiga toxin binding and membrane organization, Biophys Lett, vol.108, pp.2775-2778, 2015.

B. Haller, O. Staufer, Y. Dreher, U. Mersdorf, P. I. Spatz et al., One-pot assembly of complex giant unilamellar vesicle-based synthetic cells, ACS Synth Biol, vol.8, pp.937-947, 2019.

T. Falguie, C. Baron, D. Hanau, C. Lingwood, B. Goud et al., Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes, Mol Biol Cell, vol.12, pp.2453-2468, 2001.

G. Fuchs, M. Mobassaleh, A. Donohue-rolfe, R. K. Montgomery, R. J. Grand et al., Pathogenesis of shigella diarrhea: rabbit intestinal cell microvillus membrane binding site for shigella toxin, Infect Immun, vol.53, pp.372-377, 1986.

S. Aigal and C. , Plasma membrane reorganization: a glycolipid gateway for microbes, Biochim Biophys Acta, vol.1853, pp.858-871, 2015.

L. Berland, K. Gaus, B. Windschiegl, M. Aly, V. Fraisier et al., Shiga toxin induces tubular membrane invaginations for its uptake into cells, Nature, vol.450, pp.670-675, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00323875

H. Bj?-orkelund, G. L. Andersson, and K. , Comparing the epidermal growth factor interaction with four different cell lines: intriguing effects imply strong dependency of cellular context, PLoS One, vol.6, pp.1-7, 2011.

C. Poirier, E. D. Van, B. Delord, J. L. Roux, and D. , Specific adsorption of functionalized colloids at the surface of living cells: a quantitative kinetic analysis of the receptor-mediated binding, Biochim Biophys Acta, vol.1778, pp.2450-2457, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00335857

J. Stenberg, D. Spiegelberg, H. Karlsson, and M. Nestor, Choice of labeling and cell line influences interactions between the Fab fragment AbD15179 and its target antigen CD44v6, Nucl Med Biol, vol.41, pp.140-147, 2014.

S. Bondza, E. Foy, J. Brooks, K. Andersson, J. Robinson et al., Real-time characterization of antibody binding to receptors on living immune cells, Front Immunol, vol.8, pp.1-11, 2017.

J. C. Encarnac-ßão, P. Barta, T. Fornstedt, and K. Andersson, Impact of assay temperature on antibody binding characteristics in living cells: a case study, Biomed Rep, vol.7, pp.400-406, 2017.

J. , Shiga toxins -from cell biology to biomedical applications, Nat Rev Microbiol, vol.8, pp.105-116, 2010.

M. Watanabe-takahashi, T. Sato, T. Dohi, N. Noguchi, F. Kano et al., An orally applicable Shiga toxin neutralizer functions in the intestine to inhibit the intracellular transport of the toxin, Infect Immun, vol.78, pp.177-183, 2010.

J. Mckenzie, L. Johannes, T. Taguchi, and D. Sheff, Passage through the Golgi is necessary for Shiga toxin B subunit to reach the endoplasmic reticulum, 2009.

, FEBS J, vol.276, pp.1581-1595

M. Inez-alonso, E. , B. J. , M. Inez-men-arguez, and J. A. , Low-temperature-induced Golgi tubules are transient membranes enriched in molecules regulating intra-Golgi transport, Traffic, vol.8, pp.359-368, 2007.

S. K. M?-uller, I. Wilhelm, T. Schubert, K. Zittlau, A. Imberty et al., Gb3-binding lectins as potential carriers for transcellular drug delivery, Expert Opin Drug Deliv, vol.14, pp.141-153, 2017.

J. Ryou, Y. Sohn, D. Hwang, W. Park, N. Kim et al., Engineering of bacterial exotoxins for highly efficient and receptorspecific intracellular delivery of diverse cargos, Biotechnol Bioeng, vol.113, pp.1639-1646, 2016.

M. Amessou, D. Carrez, P. D. Sarr, M. Grierson, D. S. Croisy et al., Retrograde delivery of photosensitizer (TPPp-Ob-GluOH)3 selectively potentiates its photodynamic activity, Bioconjug Chem, vol.19, pp.532-538, 2008.

T. Schubert, How synthetic membrane systems contribute to the understanding of lipid-driven endocytosis, Biochim Biophys Acta, vol.1853, pp.2992-3005, 2015.

A. Pellizzari, H. Pang, and C. A. Lingwood, Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content, Biochemistry, vol.31, pp.1363-1370, 1992.

Z. Varasteh and A. Orlova, Comparing the measured affinity of 111In-labeled ligands for cellular receptors by monitoring gamma, beta, or X-ray radiation with three different LigandTracer Ò devices, J Radioanal Nucl Chem, vol.304, pp.823-828, 2015.

, 2020 The Authors, FEBS Letters, 2020.